A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma
- Journal:
- Blood
- Published:
- Affiliations:
- 6
- Authors:
- 15
| Institutions | Authors | Share |
|---|---|---|
| National Research Center for Translational Medicine (Shanghai), China | 0.53 | |
| Ruijin Hospital, SJTU, China | 0.40 | |
| Shanghai Jiao Tong University (SJTU), China | 0.07 |